Hans Olav Melberg
Job description
I research and teach topics related to health economics and health services research. This includes cost-benefit analyses, analyses of registry data, and more theoretical works on financing and prioritization in healthcare. Feel free to take a look at the other tabs (research) and publications to learn more.
Karoline Anisdahl,
Sandre Svatun Lirhus,
Asle Wilhelm Medhus,
Bjørn Allan Moum,
Hans Olav Melberg,
Marte Lie Høivik
:
Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study
Johan Burisch,
Mirabella Zhao,
Selwyn Odes,
Peter De Cruz,
Severine Vermeire,
Charles N Bernstein
et al.:
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Hans Olav Melberg
:
Nyttig perspektiv på overvektig populasjon
Tidsskrift for Den norske legeforening 2023 DOI
Mirabella Zhao,
Sandre Svatun Lirhus,
Mikael Lördal,
Ebbe Langholz,
Torben Knudsen,
Markku Voutilainen
et al.:
Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway
Alimentary Pharmacology and Therapeutics 2022 DOI
Kristina Malene Ødegaard,
Sandre Svatun Lirhus,
Hans Olav Melberg,
Jonas Hallen,
Sigrun Halvorsen
:
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020
Kristina Malene Ødegaard,
Sandre Svatun Lirhus,
Hans Olav Melberg,
Jonas Hallen,
Sigrun Halvorsen
:
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
Sandre Svatun Lirhus,
Marte Lie Høivik,
Bjørn Moum,
Karoline Anisdahl,
Hans Olav Melberg
:
Incidence and prevalence of inflammatory bowel disease in norway and the impact of different case definitions: A nationwide registry study
Reidar Fossmark,
Maya Olaisen,
Tom Christian Martinsen,
Hans Olav Melberg
:
Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
Karoline Anisdahl,
Sandre Svatun Lirhus,
Asle Wilhelm Medhus,
Bjørn Moum,
Hans Olav Melberg,
Marte Lie Høivik
:
First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
Christoffer Bugge,
Stein Kaasa,
Erik Magnus Sæther,
Hans Olav Melberg,
Ivar Sønbø Kristiansen
:
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
BMJ Open 2021 DOI
Snorre Kverndokk,
Hans Olav Melberg
:
Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
Kristina Malene Ødegaard,
Jonas Hallen,
Sandre Svatun Lirhus,
Hans Olav Melberg,
Sigrun Halvorsen
:
Incidence, prevalence, and mortality of heart failure:
a nationwide registry study from 2013-2016
Lars Asphaug,
Maja Thiele,
Aleksander Krag,
Hans Olav Melberg
:
Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis
Hepatology 2019 DOI
Lars Asphaug,
Hans Olav Melberg
:
The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
Medical Decision Making Policy & Practice 2019 DOI
Hans Olav Melberg,
Lars Asphaug
:
Health Economics and Fatty Liver Disease
Springer Nature 2019 DOI
Elin Kjelle,
Linn Kleven,
Hilde M Olerud,
Hans Olav Melberg
:
Cost analysis of mobile radiography services for nursing home residents in Southeast Norway
Sandre Svatun Lirhus,
Marte Lie Høivik,
Bjørn Moum,
Hans Olav Melberg
:
Regional differences in anti-TNF-a therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study
Camilla Beck Olsen,
Hans Olav Melberg
:
Did adolescents in Norway respond to the elimination of copayments for general practitioner services?
Hans Olav Melberg
:
Samhandlingsreformen og kausal inferens
Michael quarterly. Supplement 2017 ARKIV
Terje P. Hagen,
Hans Olav Melberg
:
Liggetider og reinnleggelser før og etter Samhandlingsreformen.
Tidsskrift for omsorgsforskning 2016 DOI
Camilla Beck Olsen,
Hans Olav Melberg
:
Påvirker egenandeler ungdoms legebesøk?
Trygve Ottersen,
Reidun Førde,
Meetali Kakad,
Alice Kjellevold,
Hans Olav Melberg,
Atle Moen
et al.:
A new proposal for priority setting in Norway: Open and fair
Health Policy 2016 DOI
Hans Olav Melberg,
Camilla Beck Olsen,
Kine Pedersen
:
Did hospitals respond to changes in weights of Diagnosis Related Groups in Norway between 2006 and 2013?
Health Policy 2016 DOI
Jan Blomqvist,
Raitasalo Kirsimarja,
Hans Olav Melberg,
Dirk Schreckenberg,
Christine Peschel,
Justyna klingemann
et al.:
Popular images of addiction in five European countries
Oxford University Press 2016 DOI
Justin E. Bekelman,
Scott D. Halpern,
Carl Rudolf Blankart,
Julie P. Bynum,
Joachim Cohen,
Robert Fowler
et al.:
Comparison of site of death, health care utilization, and hospital expenditures for patients dying With cancer in 7 developed countries
Journal of the American Medical Association (JAMA) 2016 DOI
Emma Medin,
Fanny Goude,
Hans Olav Melberg,
Fabrizio Tediosi,
Eva Belicza,
Mikko Peltola
:
European regional differences in all-cause mortality and length of stay for patients with hip fracture
Health Economics 2015 DOI
Hans Olav Melberg,
Ida Eriksen
:
The effects of introducing an electronic prescription system with no copayments
Health Economics Review 2015 DOI
Hans Olav Melberg,
Eline Aas,
Ingrid Hjort,
lars Vorland,
Mathias Barra,
Hallstein Husbyn
et al.:
Perspektiv og prioriteringer: Rapport fra ekspertgruppen perspektiv i prioritering nedsatt av Helse- og omsorgdepartementet
2024
Gudrun Maria Waaler Bjørnelv,
Hans Olav Melberg
:
Penger, prinsipper og prioritering
Steinar Holden,
Oona Borghild Dunlop,
Styrk Fjærtoft Vik,
Ingrid Hjort,
Simen Markussen,
Hans Olav Melberg
et al.:
Holden-IV (covid-19) Hovedrapport: Samfunnsøkonomiske vurderinger av smitteverntiltak
2022
Reidar Fossmark,
Maya Olaisen,
Tom Christian Martinsen,
Hans Olav Melberg
:
P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis
Journal of Crohn's and Colitis 2020 DOI
Reidar Fossmark,
Maya Olaisen,
Tom Christian Martinsen,
Hans Olav Melberg
:
Forskjeller i medikamentoverlevelse mellom perorale mesalazin-preparater som monoterapi ved ulcerøs colitt
2020
Linda Hildegard Bergersen,
Aasta Marie Bjorvand Bjørkøy,
Evandro Fei Fang,
Olav Gjelsvik,
Lene Hystad Hove,
Janicke Liaaen Jensen
et al.:
Vi må kunne tenke nytt om alderdom
Tore Tennøe,
Hilde Lovett,
Erik Fosse,
Siri B Hatlen,
Steinar Madsen,
Damoun Nassehi
et al.:
Kunstig Intelligens og Norske Helsedata
2019
Hans Olav Melberg
:
Value in health: How it is defined and used in priority setting and pricing in Norway
HealthcarePapers 2019 DOI
Phoi Phoi Diep,
Hans Olav Melberg,
Lorentz Brinch,
Jochen Buechner,
Yngvar Fløisand,
Thobias Gedde-Dahl
et al.:
Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
Bone Marrow Transplantation 2018 DOI
Hilde Lovett,
Damoun Nassehi,
Erik Fosse,
Siri B Hatlen,
Steinar Madsen,
Hans Olav Melberg
et al.:
Kunstig Intelligens - Muligheter, Utfordringer og en Plan for Norge
2018
Hans Olav Melberg
:
Obama-reformen – og norsk helsepolitikk
Dagens medisin 05. May 2018
Hans Olav Melberg
:
Registertilgang i molboland?
Dagens medisin 2018
Hans Olav Melberg
:
Hvorfor koster diamanter mer enn vann?
Dagens medisin 2018
Hans Olav Melberg
:
Helse-Norge trenger tvil – ikke bare heiarop
Dagens medisin 09. March 2018
Elin Kjelle,
Linn Kleven,
Hilde M Olerud,
Hans Olav Melberg
:
Radiography on wheels for nursing home residents may reduce healthcare costs
2018
Phoi Phoi Diep,
Hans Olav Melberg,
Lorentz Brinch,
Jochen Buechner,
Yngvar Fløisand,
Thobias Gedde-Dahl
et al.:
Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009:
Cost-utility and survival in children and young adults
2017
Hilde Lovett,
Tore Tennøe,
Ola Dale,
Nils Jørgen Langtvedt,
Hans Olav Melberg,
Steinar Madsen
et al.:
Mobile Selvtester
2016
Hans Olav Melberg
:
Medisiner i ingenmannsland – mens tiden går…
Dagens medisin 18. April 2016
Hans Olav Melberg
:
Skal det være en app –eller to?
Dagens medisin 18. January 2016
Hans Olav Melberg
:
Helse og finansiering i Norge
2015
Hans Olav Melberg
:
Effekter av politiske reformer: Hvorfor går det ofte galt?
2015
Hans Olav Melberg
:
Bruker vi de store pengene på de største problemene?
2015
Hans Olav Melberg
:
Jordbær, finansiering - og informasjon i norsk helsevesen
Dagens medisin 08. September 2014 FULLTEKST
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
I am broadly interested and engaged in various research questions within health economics and health services research. I particularly focus on how to utilize large registry data (such as the Norwegian Patient Registry, etc.) to answer questions such as: What is the impact of diseases on work ability? What is the effect of policy reforms and changes in reimbursement systems on healthcare consumption? How do hospitals and municipalities react to changes in financial incentives in healthcare, such as changes in the fee the municipality has to pay for patients who are ready for discharge but need to stay in the hospital? What is the proper balance between fixed salary and bonus-based financing systems?
I sometimes publish short and unpolished videos to explain some of the topics I teach and research, see here.
Teaching
HEL 3007 Health Economics
